biote Statistics
Total Valuation
biote has a market cap or net worth of $83.19 million. The enterprise value is $186.65 million.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 35.55 million shares outstanding. The number of shares has increased by 4.52% in one year.
| Current Share Class | 30.33M |
| Shares Outstanding | 35.55M |
| Shares Change (YoY) | +4.52% |
| Shares Change (QoQ) | +16.77% |
| Owned by Insiders (%) | 13.41% |
| Owned by Institutions (%) | 45.21% |
| Float | 19.62M |
Valuation Ratios
The trailing PE ratio is 5.46 and the forward PE ratio is 10.72.
| PE Ratio | 5.46 |
| Forward PE | 10.72 |
| PS Ratio | 0.44 |
| Forward PS | 0.43 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.89 |
| P/OCF Ratio | 2.56 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.68, with an EV/FCF ratio of 6.46.
| EV / Earnings | 11.96 |
| EV / Sales | 0.99 |
| EV / EBITDA | 5.68 |
| EV / EBIT | 6.17 |
| EV / FCF | 6.46 |
Financial Position
The company has a current ratio of 1.29
| Current Ratio | 1.29 |
| Quick Ratio | 0.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.22 |
| Debt / FCF | 3.75 |
| Interest Coverage | 3.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 17.81% |
| Return on Invested Capital (ROIC) | 52.51% |
| Return on Capital Employed (ROCE) | 49.77% |
| Weighted Average Cost of Capital (WACC) | 9.92% |
| Revenue Per Employee | $843,776 |
| Profits Per Employee | $69,973 |
| Employee Count | 223 |
| Asset Turnover | 1.77 |
| Inventory Turnover | 3.11 |
Taxes
In the past 12 months, biote has paid $5.03 million in taxes.
| Income Tax | 5.03M |
| Effective Tax Rate | 21.45% |
Stock Price Statistics
The stock price has decreased by -33.90% in the last 52 weeks. The beta is 1.66, so biote's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | -33.90% |
| 50-Day Moving Average | 1.97 |
| 200-Day Moving Average | 2.43 |
| Relative Strength Index (RSI) | 63.57 |
| Average Volume (20 Days) | 229,394 |
Short Selling Information
The latest short interest is 1.62 million, so 4.57% of the outstanding shares have been sold short.
| Short Interest | 1.62M |
| Short Previous Month | 1.48M |
| Short % of Shares Out | 4.57% |
| Short % of Float | 8.28% |
| Short Ratio (days to cover) | 8.17 |
Income Statement
In the last 12 months, biote had revenue of $188.16 million and earned $15.60 million in profits. Earnings per share was $0.43.
| Revenue | 188.16M |
| Gross Profit | 131.93M |
| Operating Income | 30.27M |
| Pretax Income | 23.47M |
| Net Income | 15.60M |
| EBITDA | 32.86M |
| EBIT | 30.27M |
| Earnings Per Share (EPS) | $0.43 |
Full Income StatementBalance Sheet
The company has $5.32 million in cash and $108.42 million in debt, with a net cash position of -$103.10 million or -$2.90 per share.
| Cash & Cash Equivalents | 5.32M |
| Total Debt | 108.42M |
| Net Cash | -103.10M |
| Net Cash Per Share | -$2.90 |
| Equity (Book Value) | -47.96M |
| Book Value Per Share | -1.87 |
| Working Capital | 8.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $32.63 million and capital expenditures -$3.75 million, giving a free cash flow of $28.88 million.
| Operating Cash Flow | 32.63M |
| Capital Expenditures | -3.75M |
| Depreciation & Amortization | 2.59M |
| Net Borrowing | -57.33M |
| Free Cash Flow | 28.88M |
| FCF Per Share | $0.81 |
Full Cash Flow StatementMargins
Gross margin is 70.12%, with operating and profit margins of 16.08% and 8.29%.
| Gross Margin | 70.12% |
| Operating Margin | 16.08% |
| Pretax Margin | 12.47% |
| Profit Margin | 8.29% |
| EBITDA Margin | 17.46% |
| EBIT Margin | 16.08% |
| FCF Margin | 15.35% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.52% |
| Shareholder Yield | -4.52% |
| Earnings Yield | 18.68% |
| FCF Yield | 34.57% |
Analyst Forecast
The average price target for biote is $2.99, which is 27.78% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.99 |
| Price Target Difference | 27.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 3.96% |
| EPS Growth Forecast (3Y) | 2.76% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 3.04 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.04 |
| Piotroski F-Score | 6 |
